The effect of remote nutrition therapy using Information and Communication Technology has on the glycemic control of type 2 diabetes patients : a randomized controlled trial

The effect of remote nutrition therapy using Information and Communication Technology has on the glycemic control of type 2 diabetes patients : a randomized controlled trial - Research of remote nutrition therapy programs using ICT to patients with type 2 diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018295

Enrollment

Registered

2016-01-01

Start date

2017-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

The subjects were 15 type 2 diadetes who participated in a nutrition therapy using teleconference system by managerial dietician (dietry instraction was 4 times). The subjects were 15 type 2 diadetes

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Has been diagnosed with Type 2 Diabetes HbA1c(NGSP) is more than 6.5% and not more than 9.5%.

Exclusion criteria

Exclusion criteria: Those whose HbA1c has worsen by more than 1% over the last 3 months, and/or has failed to reach treatment goals and assessed to need immediate care. Those who are undergoing intensive care for cardiovascular, cerebrovascular and kindney disease. Those who are participating in other interventional clinical trials. Those for other reasons, who are decided as inadequate for subjects by their doctor.

Design outcomes

Primary

Measure	Time frame
HbA1c (baseline, Nutrition education 1st, 2nd, 3rd, 4th) HbA1c, the upper limit of the bilateral 95% CI: below the 0.40% pre-defined as the non-inferiority margin.	—

Secondary

Measure	Time frame
BMI, % body fat, blood pressure, diet behavior, nutrient intake (baseline, Nutrition education 1st, 2nd, 3rd, 4th)	—

Countries

Japan

Contacts

Public ContactHiroyasu Mori

Tokushima University Diabetes Therapeutics and Research Center

mori.hiroyasu@tokushima-u.ac.jp0886337587

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026